Itron (NASDAQ:ITRI) SVP Sells $76,429.71 in Stock

Itron, Inc. (NASDAQ:ITRIGet Free Report) SVP Christopher Ware sold 763 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $100.17, for a total transaction of $76,429.71. Following the completion of the sale, the senior vice president directly owned 31,043 shares of the company’s stock, valued at $3,109,577.31. The trade was a 2.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Itron Price Performance

Shares of ITRI traded down $4.33 during mid-day trading on Monday, hitting $95.21. The company’s stock had a trading volume of 2,762,408 shares, compared to its average volume of 824,922. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.80 and a quick ratio of 1.56. The firm has a 50-day moving average price of $97.72 and a 200 day moving average price of $109.93. Itron, Inc. has a fifty-two week low of $88.57 and a fifty-two week high of $142.00. The stock has a market capitalization of $4.28 billion, a price-to-earnings ratio of 14.63, a PEG ratio of 0.86 and a beta of 1.48.

Itron (NASDAQ:ITRIGet Free Report) last released its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, beating the consensus estimate of $2.19 by $0.27. The business had revenue of $571.66 million during the quarter, compared to analyst estimates of $561.31 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. The business’s quarterly revenue was down 6.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.35 earnings per share. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, research analysts predict that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Institutional Investors Weigh In On Itron

A number of institutional investors have recently modified their holdings of ITRI. Vanguard Group Inc. grew its holdings in shares of Itron by 2.3% during the 3rd quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company’s stock valued at $731,809,000 after acquiring an additional 132,329 shares in the last quarter. Impax Asset Management Group plc grew its stake in Itron by 127.3% in the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after purchasing an additional 890,040 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Itron by 18.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,271,042 shares of the scientific and technical instruments company’s stock worth $118,034,000 after purchasing an additional 194,768 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Itron by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company’s stock valued at $106,340,000 after buying an additional 6,598 shares during the last quarter. Finally, Handelsbanken Fonder AB grew its stake in shares of Itron by 6.0% in the 3rd quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company’s stock valued at $124,545,000 after buying an additional 56,318 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Analyst Upgrades and Downgrades

ITRI has been the topic of a number of recent analyst reports. Zacks Research lowered Itron from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 28th. Johnson Rice upgraded Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective on the stock in a report on Monday, January 5th. Stephens raised shares of Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 price objective for the company in a research note on Monday, November 3rd. Weiss Ratings cut shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Finally, Oppenheimer lifted their price objective on shares of Itron from $125.00 to $133.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 18th. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $137.90.

Get Our Latest Analysis on Itron

More Itron News

Here are the key news stories impacting Itron this week:

About Itron

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

See Also

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.